Cellectis S.A. American Depositary Shares
Symbol: CLLS (NASDAQ)
3.28
▲ (15.05%) 0.429
Company Description:
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Key Stats
- Today's Open: $3
- Today's High: $3.335
- Today's Low: $2.899
- Today's Volume: 171.78K
- Yesterday Close: $2.85
- Yesterday High: $2.85
- Yesterday Low: $2.71
- Yesterday Volume: 60.96K
- Last Min Volume: 50
- Last Min High: $3.275
- Last Min Low: $3.275
- Last Min VWAP: $3.275
Company Profile
- Name: Cellectis S.A. American Depositary Shares
- Website: https://www.cellectis.com
- Listed Date: 2015-03-25
- Location: ,
- Market Status: Active
- CIK Number: 0001627281
- SIC Code:
- SIC description:
- Market Cap: $285.93M
- Round Lot: 100
- Outstanding Shares: 100.33M
- Asset Type: ADRC
RECENT FILINGS FOR CLLS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | S-8 | View |
| 2025-08-04 | 6-K | View |
| 2025-08-04 | 6-K | View |
| 2025-07-28 | 6-K | View |
| 2025-07-11 | EFFECT | View |
| 2025-07-09 | CORRESP | View |
| 2025-07-07 | UPLOAD | View |
| 2025-07-02 | F-3 | View |
| 2025-06-26 | 6-K | View |
| 2025-06-26 | 6-K | View |
| 2025-05-21 | 6-K | View |
| 2025-05-21 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-06 | 6-K | View |
| 2025-04-28 | 6-K | View |
| 2025-03-31 | 6-K | View |
| 2025-03-14 | 20-F/A | View |
| 2025-03-14 | 20-F | View |
| 2025-03-07 | 6-K | View |
Latest News on CLLS